UBE2T promotes a variety of biological functions in CSCs (self-renewal, drug resistance, tumorigenicity, and metastatic ability), and UBE2T inhibition can regulate CSC-induced tumor recurrence and treatment resistance [11]. The gene discussed is UBE2T; the disease is neoplasm.